WHITE PAPER:
Accurate & Efficient Pharmacogenomics
Maximizing ROI Through Cost-Efficient Molecular Analysis
Maximize Your Lab's PGx ROI
The demand for precise and efficient pharmacogenomics (PGx) analysis is at an all-time high. PGx analysis has seen a rapid increase in the number of necessary targets and evidence of gene/drug interactions. Labs require more than the standard limitation of 3-6 targets per reaction that other technologies offer. Labs must analyze 10s to 100s of variants and manage multiple workflows. Our latest white paper reveals the unparalleled cost-saving and operational benefits of the MassARRAY® System, making it the leading solution for labs seeking to enhance their PGx analysis capabilities.
Experience high-volume, efficient PGx analysis with over 30% savings and ROI within 1.5 years. In this white paper you’ll learn:
- How your PGx lab can drastically reduce costs through various means, including no reagent waste, no unnecessary testing replicates, and the system's high multiplexing capability.
- How the economic benefits of implementing the MassARRAY System extend beyond cost savings.
- How the MassARRAY System reduces costs by running both genotypes and copy number variations (CNVs) in one smooth workflow without the need for costly bioinformatics support.
Complete the form to view the white paper on the economics of PGx analysis.
Access the White Paper
Complete the form to view the white paper on the economics of PGx analysis.